Italia markets closed

BMY Jun 2024 44.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,7700-0,5500 (-41,67%)
In data: 09:40AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,8700
Aperto0,8200
Denaro0,7200
Lettera0,7600
Prezzo d'esercizio44,00
Scadenza2024-06-21
Min-Max giorno0,7700 - 0,9000
Contratto - Min-MaxN/D
Volume177
Open Interest4,16k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri